Viral Responses - Hepatitis

Measuring Immunity: Basic Biology and Clinical Assessment

Volumn , Issue , 2005, Pages 598-609

  Kanto, Tatsuya ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68949135962     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012455900-4/50314-7     Document Type: Chapter

References (79)

1. Bain C., Fatmi A., Zoulim F., Zarski J.P., Trepo C., Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 2001, 120:512-524.
2. Banchereau J., Banchereau J., Briere F., Caux C., et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
3. Barnes E., Harcourt G., Brown D., et al. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 2002, 36:743-754.
4. Beckebaum S., Cicinnati V.R., Dworacki G., et al. Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol 2002, 104:138-150.
5. Bertoletti A., Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology 2003, 38:4-13.
6. Boni C., Penna A., Ogg G.S., et al. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 2001, 33:963-971.
7. Chang K.M., Thimme R., Melpolder J.J., et al. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 2001, 33:267-276.
8. Cooper S., Erickson A.L., Adams E.J., et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999, 10:439-449.
9. Cramp M.E., Rossol S., Chokshi S., Carucci P., Williams R., Naoumov N.V. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 2000, 118:346-355.
10. Crispe I.N. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003, 3:51-62.
11. Crotta S., Stilla A., Wack A., et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 2002, 195:35-41.
12. Day C.L., Lauer G.M., Robbins G.K., et al. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol 2002, 76:12584-12595.
13. Day C.L., Seth N.P., Lucas M., et al. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class ll tetramers. J Clin Invest 2003, 112:831-842.
14. Diepolder H.M., Zachoval R., Hoffmann R.M., et al. Possible mechanism involving T-lymphocyte response to nonstructural protein 3 in viral clearance in acute hepatitis C virus infection. Lance 1995, 346:1006-1007.
15. Dzionek A., Fuchs A., Schmidt P., et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000, 165:6037-6046.
16. Farci P., Alter H.J., Wong D.C., et al. Prevention of hepatitis C virus infection in chimpanzees after antibody mediated in vitro neutralization. Proc Natl Acad Sci. USA 1994, 91:7792-7796.
17. Fong T.L., Di Bisceglie A.M., Biswas R., et al. High levels of viral replication during acute hepatitis B infection predict progression to chronicity. J Med Virol 1994, 43:155-158.
18. Foy E., Li K., Wang C., et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 2003, 300:1145-1148.
19. Goutagny N., Fatmi A., De Ledinghen V., et al. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 2003, 187:1951-1958.
20. Grabowska A.M., Lechner F., Klenerman P., et al. Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. Eur J Immunol 2001, 31:2388-2394.
21. Grakoui A., Shoukry N.H., Willard D.J., et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 2003, 302:659-662.
22. Gruener N.H., Lechner F., Jung M.C., et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 2001, 75:5550-5558.
23. Guidotti L.G., Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001, 19:65-91.
24. He X.S., Rehermann B., Lopez-Labrador F.X., et al. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci USA 1999, 96:5692-5697.
25. Heil F., Ahmad-Nejad P., Hemmi H., et al. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur J Immunol 2003, 33:2987-2997.
26. Hiroishi K., Kita H., Kojima M., et al. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection. Hepatology 1997, 25:705-712.
27. Jinushi M., Takehara T., Kanto T., et al. Critical role of MHC class l-related chain A and B expression on IFN-alphastimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J Immunol 2003, 170:1249-1256.
28. Kadowaki N., Ho S., Antonenko S., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001, 194:863-869.
29. Kakimi K., Guidotti L.G., Koezuka Y., Chisari F.V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000, 192:921-930.
30. Kamal S.M., Fehr J., Roesler B., Peters T., Rasenack J.W. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology 2002, 123:1070-1083.
31. Kanto T., Hayashi N., Takehara T., et al. Impaired alliostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol 1999, 162:5584-5591.
32. Kanto T., Sato A., Inoue M., et al. FN-gamma or Il-15 restores the impaired helper T cell polarizing ability of blood dendritic cell subsets in chronic hepatitis C. Hepatology 2003, 38(Suppl. 1):342A.
33. Kittlesen D.J., Chianese-Bullock K.A., Yao Z.Q., Braciale T.J., Hahn Y.S. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest 2000, 106:1239-1249.
34. Koziel M.J., Wong D.K., Dudley D., Houghton M., Walker B.D. Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J Infect Dis 1997, 176:859-866.
35. Lau A.H., Thomson A.W. Dendritic cells and immune regulation in the liver. Gut 2003, 52:307-314.
36. Lauer G.M., Ouchi K., Chung R.T., et al. Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J Virol 2002, 76:6104-6113.
37. Lechner F., Cuero A.L., Kantzanou M., Klenerman P. Studies of human antiviral CD8+ lymphocytes using class l peptide tetramers. Rev Med Virol 2001, 11:11-22.
38. Lechner F., Wong D.K., Dunbar P.R., et al. Analysis of suocessful immune responses in persons in fected with hepatitis C virus. J Exp Med 2000, 191:1499-1512.
39. Leroy V., Vigan I., Mosnier J.F., et al. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepathology 2003, 38:829-841.
40. Liang T.J., Rehermann B., Seeff L.B., Hoofnagle J.H. Pathogenesis, natural history treatment, and prevention of hepatitis C. Ann Intern Med 2000, 132:296-305.
41. Liu Y.J., Kadowaki N., Rissoan M.C., Soumelis V. T cell activation and polarization by DC1 and DC2. Curr Top Microbiol Immunol 2000, 251:149-159.
42. Lohr H.F., Pingel S., Bocher W.O., et al. Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B-restoration by exogenous interleukin-12. Clin Exp Immunol 2002, 130:107-114.
43. Lok A.S., McMahon B.J. Chronic hepatitis B. Hepatology 2001, 34:1225-1241.
44. Longman R.S., Talal A.H., Jacobson I.M., Albert M.L., Rice C.M. Patients chronically infected with hepatitis C virus have functional dendritic cells. Blood 2003.
45. Lyons A.B. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 2000, 243:147-154.
46. Maini M.K., Boni C., Lee C.K., et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000, 191:1269-1280.
47. Maini M.K., Boni C., Ogg G.S., et al. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology 1999, 117:1386-1396.
48. Nascimbeni M., Mizukoshi E., Bosmann M., et al. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol 2003, 77:4781-4793.
49. Nelson D.R., Marousis C.G., Davis G.L., et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997, 158:1473-1481.
50. Penna A., Artini M, Cavalli A., et al. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 1996, 98:1185-1194.
51. Penna A., Missale G., Lamonaca V., et al. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis. Hepatology 2002, 35:1225-1236.
52. Prezzi C., Casciaro M.a., Francavilla V., et al. Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection. Eur J Immunol 2001, 31:894-906.
53. Rehermann B., Chang K.M., McHutchinson J., et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996, 70:7092-7102.
54. Rehermann B., Chang K.M., McHutchison J.G., Kokka R., Houghton M., Chisari F.V. Quantitative analysis of the periperal blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 1996, 98:1432-1440.
55. Rehermann B., Lau D., Hoofnagle J.H., Chisari F.V. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest 1996, 97:1655-1665.
56. Reignat S., Webster G.J., Brown D., et al. Escaping high viral load exhaustion: CD8 cells with altered tetramer, binding in chronic hepatitis B virus infection. J Exp Med 2002, 195:1089-1101.
57. Rico M.A., Quiroga J.A., Subira D., et al. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. Hepatology 2001, 33:295-300.
58. Rollier C., Drexhage J.A., Verstrepen B.E., et al. Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment. Hepatology 2003, 38:851-858.
59. Romani N., Gruner S., Brang D., et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994, 180:83-93.
60. Rubio-Godoy V., Dutoit V., Rimoldi D., et al. Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life. Proc Natl Acad Sci USA 2001, 98:10302-10307.
61. Sarobe P., Lasarte J.J., Casares N., et al. Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J Virol 2002, 76:5062-5070.
62. Schirren C.A., Jung M.C., Gerlach J.T., et al. Liverderived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatology 2000, 32:597-603.
63. Scognamiglio P., Accapezzato D., Casciaro M.A., et al. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. J Immunol 1999, 162:6681-6689.
64. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002, 2:151-161.
65. Shoukry N.H., Grakoui A., Houghton M., et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 2003, 197:1645-1655.
66. Soumelis V., Scott I., Gheyas F., et al. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 2001, 98:906-912.
67. Su A.I., Pezacki J.P., Wodicka L., et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA 2002, 99:15669-15674.
68. Takaki A., Wiese M., Maertens G., et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000, 6:578-582.
69. Taylor D.R., Shi S.T., Romano P.R., Barber G.N., Lai M.M. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 1999, 285:107-110.
70. Thimme R., Bukh J., Spangenberg H.C., et al. Viral and immunological determinants of hepatitis C virus clearance, persistance, and disease. Proc Natl Acad Sci USA 2002, 99:15661-15668.
71. Thimme R., Oldach D., Chang K.M., Steiger C., Ray S.C., Chisari F.V. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001, 194(10):1395-1406.
72. Thimme R., Wieland S., Steiger C., et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003, 77:68-76.
73. Ulsenheimer A., Gerlach J.T., Gruener N.H., et al. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 2003, 37:1189-1198.
74. Urbani S., Boni C., Missale G., et al. Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J Virol 2002, 76:12423-12434.
75. Webster G.J., Reignat S., Maini M.K., et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 2000, 32:1117-1124.
76. Wedemeyer H., He X.S., Nascimbeni M., et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002, 169:3447-3458.
77. Wertheimer A.M., Miner C., Lewinsohn D.M., Sasaki A.W., Kaufman E., Rosen H.R. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with, spontaneously resolved HCV infection. Hepatology 2003, 37:577-589.
78. Wong D.K., Dudley D.D., Afdhal N.H., et al. Liverderived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J Immunol 1998, 160:1479-1488.
79. Zhang J., Randall G., Higginbottom A., Monk P., Rice C.M., McKeating J.A. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol 2004, 78:1448-1455.